Clinical Characteristics, and Antibiotic Effectiveness in the First 48 Hours in Children Under 5 Years of Age with Bacterial Dysentery
,
Abstract
Background: Bacterial dysentery is diarrhea with blood (plus or minus mucus), indicating an invasive infection. With effective antibiotic treatment, clinical improvement occurs within 48 hours, which leads to a reduction in the risk of serious complications and death, a shorter duration of illness, and a reduction in transmission. This study was conducted to investigate the clinical features, risk factors, and effectiveness of antibiotics in the first 48 hours in children under 5 years old with bacterial dysentery.
Method: In this cross-sectional descriptive-analytical study, children less than 5 years old with bacterial dysentery were hospitalized in Ali Ibn Abitaleb and Ali Asghar Hospital in Zahedan, Iran. After obtaining the necessary permits from the ethics committee, the researcher extracted the information on 85 cases of patients diagnosed with bacterial dysentery, taking into account the entry and exit criteria in an accessible way. The information was entered into the questionnaire.
Results: The mean age of the patients was 31.17±16.04 months. 52.9% of patients were girls (n=45). Fever was observed in 100% of patients(n=85). The severity of mild, moderate, and severe dehydration was observed in 36.47%, 40%, and 25.53% of the patients, respectively. The most injected antibiotic was ceftriaxone. White blood cell (WBC) levels decreased significantly after receiving treatment (antibiotic). (before treatment: 13.22±9.91 and after treatment: 8.57±2.71 cells/microliter, P-value=0.001).
Conclusion: Our study showed that antibiotic treatment in bacterial dysentery effectively reduces the serum level of WBC. It is suggested that educational programs for mothers in the field of child nutrition be provided and that the effectiveness of different types of antibiotics be compared in future studies.
2. Walker CLF, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA, et al. Global burden of childhood pneumonia and diarrhoea. The Lancet. 2013;381(9875):1405-16.
3. Jain PA, Kulkarni RD, Dutta S, Ganavali AS, Kalabhavi AS, Shetty PC, et al. Prevalence and antimicrobial profile of Shigella isolates in a tertiary care hospital of North Karnataka: a 12-year study. Indian J Med Microbiol. 2020;38(1):101-08.
4. Kotloff KL, Riddle MS, Platts-Mills JA, Pavlinac PZaidi AK. Shigellosis. The Lancet. 2018;391(10122):801-12.
5. Vubil D, Acácio S, Quintò L, Ballesté-Delpierre C, Nhampossa T, Kotloff K, et al. Clinical features, risk factors, and impact of antibiotic treatment of diarrhea caused by Shigella in children less than 5 years in Manhiça District, rural Mozambique. Infect Drug Resist. 2018:2095-106.
6. Schnupf PSansonetti PJ. Shigella pathogenesis: new insights through advanced methodologies. Bacteria and Intracellularity. 2019:15-39.
7. Williams PCBerkley JA. Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence. J Paediatr Child Health. 2018;38(sup1):S50-S65.
8. Hussen S, Mulatu GYohannes Kassa Z. Prevalence of Shigella species and its drug resistance pattern in Ethiopia: a systematic review and meta-analysis. Ann Clin Microbiol Antimicrob. 2019;18:1-11.
9. Mokomane M, Kasvosve I, Melo Ed, Pernica JMGoldfarb DM. The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management. Ther. Adv. Infect. Dis. 2018;5(1):29-43.
10. Ferdous F, Ahmed S, Das S, Farzana F, Latham J, Chisti M, et al. Aetiology and clinical features of dysentery in children aged< 5 years in rural Bangladesh. Epidemiol Infect 2014;142(1):90-98.
11. Traa BS, Walker CLF, Munos MBlack RE. Antibiotics for the treatment of dysentery in children. Int J Epidemiol. 2010;39(suppl_1):i70-i74.
12. Cohen R, Raymond JGendrel D. Antimicrobial treatment of diarrhea/acute gastroenteritis in children. Archives de Pédiatrie. 2017;24(12):S26-S29.
13. Ali Nor BS, Menza NCMusyoki AM. Multidrug‐Resistant Shigellosis among Children Aged below Five Years with Diarrhea at Banadir Hospital in Mogadishu, Somalia. Can J Infect Dis Med Microbiol. 2021;2021(1):6630272.
14. Jahan Y, Moriyama M, Hossain S, Rahman MM, Ferdous F, Ahmed S, et al. Relation of childhood diarrheal morbidity with the type of tube well used and associated factors of Shigella sonnei diarrhea in rural Bangladesh site of the Global Enteric Multicenter Study. Tropical medicine and health. 2019;47:1-10.
15. Rogawski McQuade ET, Shaheen F, Kabir F, Rizvi A, Platts-Mills JA, Aziz F, et al. Epidemiology of Shigella infections and diarrhea in the first two years of life using culture-independent diagnostics in 8 low-resource settings. PLoS neglected tropical diseases. 2020;14(8):e0008536.
16. Posovszky C, Buderus S, Classen M, Lawrenz B, Keller K-MKoletzko S. Acute infectious gastroenteritis in infancy and childhood. Deutsches Ärzteblatt International. 2020;117(37):615.
17. Anigilaje EA. Management of diarrhoeal dehydration in childhood: A review for clinicians in developing countries. Front. Pediatr. 2018;6:28.
18. Sharma A, Mathur A, Stålsby Lundborg CPathak A. Incidence and risk factors for severe dehydration in hospitalized children in Ujjain, India. Int J Environ Res Public Health. 2020;17(2):616.
19. Christopher PR, David KV, John SMSankarapandian V. Antibiotic therapy for Shigella dysentery. Cochrane Database of Systematic Reviews. 2010(8).
| Files | ||
| Issue | Vol 6, No 4 (2023) | |
| Section | Original Article | |
| DOI | https://doi.org/10.18502/igj.v6i4.17100 | |
| Keywords | ||
| Bacterial Dysentery Antibiotics Diarrhea Infection | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
